Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Qiagen

    World Rank (Jan-05-2024)
    1,657
    Market Cap (Jan-05-2024)
    9.994 Billion USD
    World Rank (Jul-30-2023)
    1,592
    Market Cap (Jul-30-2023)
    10.745 Billion USD
    World Rank (Dec-25-2022)
    1,395
    Market Cap (Dec-25-2022)
    11.228 Billion USD
    World Rank (Jan-07-2022)
    1,676
    Market Cap (Jan-07-2022)
    11.46 Billion USD
    Annual Revenue in USD
    2,141 Million USD
    Annual Operating Income in USD
    576 Million USD
    Annual Net Income in USD
    423 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pharmaceutical and research company with headquarters is in Germany.

  2. Exelixis

    World Rank (Jan-05-2024)
    2,140
    Market Cap (Jan-05-2024)
    7.383 Billion USD
    World Rank (Jul-30-2023)
    2,387
    Market Cap (Jul-30-2023)
    6.464 Billion USD
    World Rank (Dec-25-2022)
    2,676
    Market Cap (Dec-25-2022)
    5.106 Billion USD
    World Rank (Jan-07-2022)
    2,857
    Market Cap (Jan-07-2022)
    5.93 Billion USD
    Annual Revenue in USD
    1,611 Million USD
    Annual Operating Income in USD
    201 Million USD
    Annual Net Income in USD
    182 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Exelixis is a Commercially successful and Oncology Focused Biotechnology company. The company established a broad drug discovery and development platform that has served as the foundation for continued efforts to bring new cancer therapies to patients in need. Headquarters is in USA.

  3. CRISPR Therapeutics AG

    World Rank (Jan-05-2024)
    2,937
    Market Cap (Jan-05-2024)
    4.970 Billion USD
    World Rank (Jul-30-2023)
    3,257
    Market Cap (Jul-30-2023)
    4.491 Billion USD
    World Rank (Dec-25-2022)
    3,680
    Market Cap (Dec-25-2022)
    3.452 Billion USD
    World Rank (Jan-07-2022)
    3,187
    Market Cap (Jan-07-2022)
    5.18 Billion USD
    Annual Revenue in USD
    914 Million USD
    Annual Net Income in USD
    377 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Biotechnology company and gene editing company to control couple of human diseases like Cancer and couple of other diseases and it's headquarters is in Switzerland.

    With CRISPR/Cas9, they aim to target the source of genetically-defined diseases and engineer the next generation of cellular therapies

  4. Halozyme Therapeutics

    World Rank (Jan-05-2024)
    3,006
    Market Cap (Jan-05-2024)
    4.828 Billion USD
    World Rank (Jul-30-2023)
    2,631
    Market Cap (Jul-30-2023)
    5.749 Billion USD
    World Rank (Dec-25-2022)
    1,883
    Market Cap (Dec-25-2022)
    7.773 Billion USD
    World Rank (Jan-07-2022)
    3,159
    Market Cap (Jan-07-2022)
    5.25 Billion USD
    Annual Revenue in USD
    660 Million USD
    Annual Net Income in USD
    202 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Halozyme Therapeutics is a Biotechnology Company focused on novel biological and drug delivery approaches. It is having approximately 130 employees. The headquarters is in USA.

  5. Revolution Medicines Inc.

    World Rank (Jan-05-2024)
    3,149
    Market Cap (Jan-05-2024)
    4.591 Billion USD
    World Rank (Jul-30-2023)
    4,655
    Market Cap (Jul-30-2023)
    2.733 Billion USD
    World Rank (Dec-25-2022)
    5,525
    Market Cap (Dec-25-2022)
    1.957 Billion USD
    World Rank (Jan-07-2022)
    6,958
    Market Cap (Jan-07-2022)
    1.69 Billion USD
    Annual Revenue in USD
    35 Million USD
    Annual Operating Income in USD
    -258 Million USD
    Annual Net Income in USD
    -248 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Oncology therapies developing company with headquarters is in USA.
  6. Krystal Biotech

    World Rank (Jan-05-2024)
    3,986
    Market Cap (Jan-05-2024)
    3.388 Billion USD
    World Rank (Jul-30-2023)
    4,110
    Market Cap (Jul-30-2023)
    3.259 Billion USD
    World Rank (Dec-25-2022)
    5,498
    Market Cap (Dec-25-2022)
    1.973 Billion USD
    World Rank (Jan-07-2022)
    7,197
    Market Cap (Jan-07-2022)
    1.60 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -120 Million USD
    Annual Net Income in USD
    -139 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Krystal Biotech is a Clinical Stage Gene Therapy company. It initially developing topical and intradermal "off-the-shelf" novel therapies for rare and orphan dermatological indications and expanding the use of pioneering STAR-D technology to target and treat other skin conditions as well. The headquarters is in USA.
  7. Ginkgo Bioworks Holdings Inc.

    World Rank (Jan-05-2024)
    4,113
    Market Cap (Jan-05-2024)
    3.262 Billion USD
    World Rank (Jul-30-2023)
    2,929
    Market Cap (Jul-30-2023)
    5.089 Billion USD
    World Rank (Dec-25-2022)
    3,887
    Market Cap (Dec-25-2022)
    3.220 Billion USD
    Headquarters Country
    Company Profile

    GINKGO BIOWORKS HOLDINGS, INC.is a Biotechnology Holding company, and its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Headquarters is in USA.

  8. ImmunityBio Inc.

    World Rank (Jan-05-2024)
    4,154
    Market Cap (Jan-05-2024)
    3.225 Billion USD
    World Rank (Jul-30-2023)
    8,650
    Market Cap (Jul-30-2023)
    1.016 Billion USD
    World Rank (Dec-25-2022)
    4,890
    Market Cap (Dec-25-2022)
    2.342 Billion USD
    World Rank (Jan-07-2022)
    5,471
    Market Cap (Jan-07-2022)
    2.50 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -350 Million USD
    Annual Net Income in USD
    -416 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    ImmunityBio is a Late Clinical Stage Immunotherapy company for treating cancer and infectious diseases. The headquarters is in USA.
  9. Alvotech

    World Rank (Jan-05-2024)
    4,162
    Market Cap (Jan-05-2024)
    3.219 Billion USD
    World Rank (Jul-30-2023)
    4,793
    Market Cap (Jul-30-2023)
    2.602 Billion USD
    World Rank (Dec-25-2022)
    4,680
    Market Cap (Dec-25-2022)
    2.487 Billion USD
    Headquarters Country
    Company Profile

    The company is a biotechnology company that manufactures biologic medicines like insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines. Headquarters is in Iceland.

  10. Immunocore Holdings PLC

    World Rank (Jan-05-2024)
    4,182
    Market Cap (Jan-05-2024)
    3.200 Billion USD
    World Rank (Jul-30-2023)
    4,317
    Market Cap (Jul-30-2023)
    3.041 Billion USD
    World Rank (Dec-25-2022)
    4,355
    Market Cap (Dec-25-2022)
    2.769 Billion USD
    World Rank (Jan-07-2022)
    8,234
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Annual Revenue in USD
    31 Million USD
    Annual Net Income in USD
    -154 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Immunocore is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease. Headquarters is in UK.

Share

Ads